1. Home
  2. PCSC vs IOBT Comparison

PCSC vs IOBT Comparison

Compare PCSC & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCSC
  • IOBT
  • Stock Information
  • Founded
  • PCSC 2024
  • IOBT 2014
  • Country
  • PCSC United States
  • IOBT Denmark
  • Employees
  • PCSC N/A
  • IOBT N/A
  • Industry
  • PCSC
  • IOBT Biotechnology: Pharmaceutical Preparations
  • Sector
  • PCSC
  • IOBT Health Care
  • Exchange
  • PCSC NYSE
  • IOBT Nasdaq
  • Market Cap
  • PCSC 114.2M
  • IOBT 91.6M
  • IPO Year
  • PCSC 2024
  • IOBT 2021
  • Fundamental
  • Price
  • PCSC $10.55
  • IOBT $1.44
  • Analyst Decision
  • PCSC
  • IOBT Strong Buy
  • Analyst Count
  • PCSC 0
  • IOBT 3
  • Target Price
  • PCSC N/A
  • IOBT $9.33
  • AVG Volume (30 Days)
  • PCSC 6.9K
  • IOBT 156.6K
  • Earning Date
  • PCSC 01-01-0001
  • IOBT 08-12-2025
  • Dividend Yield
  • PCSC N/A
  • IOBT N/A
  • EPS Growth
  • PCSC N/A
  • IOBT N/A
  • EPS
  • PCSC N/A
  • IOBT N/A
  • Revenue
  • PCSC N/A
  • IOBT N/A
  • Revenue This Year
  • PCSC N/A
  • IOBT N/A
  • Revenue Next Year
  • PCSC N/A
  • IOBT N/A
  • P/E Ratio
  • PCSC $45.84
  • IOBT N/A
  • Revenue Growth
  • PCSC N/A
  • IOBT N/A
  • 52 Week Low
  • PCSC $10.02
  • IOBT $0.66
  • 52 Week High
  • PCSC $10.74
  • IOBT $1.73
  • Technical
  • Relative Strength Index (RSI)
  • PCSC N/A
  • IOBT 54.11
  • Support Level
  • PCSC N/A
  • IOBT $1.37
  • Resistance Level
  • PCSC N/A
  • IOBT $1.52
  • Average True Range (ATR)
  • PCSC 0.00
  • IOBT 0.09
  • MACD
  • PCSC 0.00
  • IOBT -0.01
  • Stochastic Oscillator
  • PCSC 0.00
  • IOBT 60.30

About PCSC PERCEPTIVE CAP SOLUTIONS CORP

Perceptive Capital Solutions Corp is a blank check company.

About IOBT IO Biotech Inc.

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

Share on Social Networks: